SOX2 and melanoma: In particular, in malignant melanoma, the expression level of miR‐625 was inversely correlated with that of transcription factor SOX‐2 (SOX2), suggesting that the anti‐tumor action of miR‐625 is at least partially mediated by the inhibition of SOX2 (Fang et al., 2017).